Ramm Pharma Corp - ESG Rating & Company Profile powered by AI
The report of Ramm Pharma Corp employs data from across the web and also from public disclosures by Ramm Pharma Corp. The ESG assessment for Ramm Pharma Corp represents the company's reporting of the UN Sustainable Development Goals. The analysis of Ramm Pharma Corp was assembled by All Street Sevva using cutting edge NLP.
Ramm Pharma Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Ramm Pharma Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Ramm Pharma Corp have an accelerator or VC vehicle to help deliver innovation?
Does Ramm Pharma Corp disclose current and historical energy intensity?
Does Ramm Pharma Corp report the average age of the workforce?
Does Ramm Pharma Corp reference operational or capital allocation in relation to climate change?
Does Ramm Pharma Corp disclose its ethnicity pay gap?
Does Ramm Pharma Corp disclose cybersecurity risks?
Does Ramm Pharma Corp offer flexible work?
Does Ramm Pharma Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Ramm Pharma Corp disclose the number of employees in R&D functions?
Does Ramm Pharma Corp conduct supply chain audits?
Does Ramm Pharma Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Ramm Pharma Corp conduct 360 degree staff reviews?
Does Ramm Pharma Corp disclose the individual responsible for D&I?
Does Ramm Pharma Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Ramm Pharma Corp disclose current and / or historical scope 2 emissions?
Does Ramm Pharma Corp disclose water use targets?
Does Ramm Pharma Corp have careers partnerships with academic institutions?
Did Ramm Pharma Corp have a product recall in the last two years?
Does Ramm Pharma Corp disclose incidents of discrimination?
Does Ramm Pharma Corp allow for Work Councils/Collective Agreements to be formed?
Has Ramm Pharma Corp issued a profit warning in the past 24 months?
Does Ramm Pharma Corp disclose parental leave metrics?
Does Ramm Pharma Corp disclose climate scenario or pathway analysis?
Does Ramm Pharma Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Ramm Pharma Corp disclose the pay ratio of women to men?
Does Ramm Pharma Corp support suppliers with sustainability related research and development?
Does Ramm Pharma Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Ramm Pharma Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Ramm Pharma Corp involved in embryonic stem cell research?
Does Ramm Pharma Corp disclose GHG and Air Emissions intensity?
Does Ramm Pharma Corp disclose its waste policy?
Does Ramm Pharma Corp report according to TCFD requirements?
Does Ramm Pharma Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Ramm Pharma Corp disclose energy use targets?
Does Ramm Pharma Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Ramm Pharma Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Ramm Pharma Corp
These potential risks are based on the size, segment and geographies of the company.
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products. The company offers Epifractán, a cannabinoid pharmaceutical drug for the treatment of various medical conditions and pathologies; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. It also offers cosmetic products, such as cannabipiel nite, cannabipiel body lotion, cannabipiel hair conditioners, cannabipiel liquid soaps, cannabipiel tite, cannabipiel cleaning emulsions, cannabipiel shampoos, cannabipiel lite, and cannbipiel facial tonics. In addition, the company also engages in the agricultural business. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. The company was incorporated in 1987 and is based in Toronto, Canada.